Gustavo Nino

Dr. Gustavo Nino

Division of Pediatric Pulmonology and Sleep Medicine, Children’s National Health System, Address: 111 Michigan Avenue, NW, Washington, DC 20010, USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2018 in Children
Verified
Journal Article
Open access
PDF file
CWCandice Wolf
Candice Wolf
SWSeth Wolf
Seth Wolf
MWMiriam Weiss
Miriam Weiss
GNGustavo Nino
Gustavo Nino
The quantity, accessibility and focus on child-targeted programming has exponentially increased since it entered American households in the early 1900s. It may have started with the television (TV), but technology has evolved and now fits in our pockets; as of 2017, 95% of American families own a smartphone. Availability and child-tailored content has subsequently led to a decrease in the age at initial screen exposure. The negative effects that accompany the current culture of early screen exposure are extensive and need to be considered as technology continues to enter the home and inundate social interactions. Increased levels of early screen exposure have been associated with decreased cognitive abilities, decreased growth, addictive behavior, poor school performance, poor sleep patterns, and increased levels of obesity. Research on the adverse effects of early screen exposure is mounting, but further epidemiological studies are still needed to inform prevention and regulation policies.

30 January 2015 in Pediatric Allergy and Immunology
Verified
Journal Article
Closed access
PDF file
GPGeovanny Perez
Geovanny Perez
KPKrishna Pancham
Krishna Pancham
SHShehlanoor Huseni
Shehlanoor Huseni
AJAmisha Jain
Amisha Jain
CRCarlos E. Rodriguez‐Martinez
Carlos E. Rodriguez‐Martinez
GNGustavo Nino
Gustavo Nino

19 September 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MGMaria Gutierrez
Maria Gutierrez
JGJose L Gomez
Jose L Gomez
GPGeovanny Perez
Geovanny Perez
KPKrishna Pancham
Krishna Pancham
SVStephanie Val
Stephanie Val
GNGustavo Nino
Gustavo Nino
Innate immune responses are fine-tuned by small noncoding RNA molecules termed microRNAs (miRs) that modify gene expression in response to the environment. During acute infections, miRs can be secreted in extracellular vesicles (EV) to facilitate cell-to-cell genetic communication. The purpose of this study was to characterize the baseline population of miRs secreted in EVs in the airways of young children (airway secretory microRNAome) and examine the changes during rhinovirus (RV) infection, the most common cause of asthma exacerbations and the most important early risk factor for the development of asthma beyond childhood. Nasal airway secretions were obtained from children (≤3 yrs. old) during PCR-confirmed RV infections (n = 10) and age-matched controls (n = 10). Nasal EVs were isolated with polymer-based precipitation and global miR profiles generated using NanoString microarrays. We validated our in vivo airway secretory miR data in an in vitro airway epithelium model using apical secretions from primary human bronchial epithelial cells (HBEC) differentiated at air-liquid interface (ALI). Bioinformatics tools were used to determine the unified (nasal and bronchial) signature airway secretory miRNAome and changes during RV infection in children. Multiscale analysis identified four signature miRs comprising the baseline airway secretory miRNAome: hsa-miR-630, hsa-miR-302d-3p, hsa- miR-320e, hsa-miR-612. We identified hsa-miR-155 as the main change in the baseline miRNAome during RV infection in young children. We investigated the potential biological relevance of the airway secretion of hsa-mir-155 using in silico models derived from gene datasets of experimental in vivo human RV infection. These analyses confirmed that hsa-miR-155 targetome is an overrepresented pathway in the upper airways of individuals infected with RV. Comparative analysis of the airway secretory microRNAome in children indicates that RV infection is associated with airway secretion of EVs containing miR-155, which is predicted in silico to regulate antiviral immunity. Further characterization of the airway secretory microRNAome during health and disease may lead to completely new strategies to treat and monitor respiratory conditions in all ages.

14 September 2020 in Pediatric Pulmonology
Verified
Journal Article
Open access
PDF file
GNGustavo Nino
Gustavo Nino
JZJonathan Zember
Jonathan Zember
RSRamon Sanchez‐Jacob
Ramon Sanchez‐Jacob
MGMaria Gutierrez
Maria Gutierrez
KSKarun Sharma
Karun Sharma
MLMarius George Linguraru
Marius George Linguraru
Rationale: Pediatric COVID‐19 studies have been mostly restricted to case reports and small case series, which have prevented the identification of specific pediatric lung disease patterns in COVID‐19. The overarching goal of this systematic review and meta‐analysis is to provide the first comprehensive summary of the findings of published studies thus far describing COVID‐19 lung imaging data in the pediatric population.Methods: A systematic literature search of PubMed was performed to identify studies assessing lung‐imaging features of COVID‐19 pediatric patients (0–18 years). A single‐arm meta‐analysis was conducted to obtain the pooled prevalence and 95% confidence interval (95% CI).Results: A total of 29 articles (n = 1026 children) based on chest computerized tomography (CT) images were included. The main results of this comprehensive analysis are as follows: (1) Over a third of pediatric patients with COVID‐19 (35.7%, 95% CI: 27.5%–44%) had normal chest CT scans and only 27.7% (95% CI: 19.9%–35.6%) had bilateral lesions. (2) The most typical pediatric chest CT findings of COVID‐19 were ground‐glass opacities (GGO) (37.2%, 95% CI: 29.3%–45%) and the presence of consolidations or pneumonic infiltrates (22.3%, 95% CI: 17.8%–26.9%). (3) The lung imaging findings in children with COVID‐19 were overall less frequent and less severe than in adult patients. (4) Typical lung imaging features of viral respiratory infections in the pediatric population such as increased perihilar markings and hyperinflation were not reported in children with COVID‐19.Conclusion: Chest CT manifestations in children with COVID‐19 could potentially be used for early identification and prompt intervention in the pediatric population.

25 June 2014 in European Respiratory Journal
Verified
Journal Article
Closed access
PDF file
GPGeovanny F. Perez
Geovanny F. Perez
KPKrishna Pancham
Krishna Pancham
SHShehlanoor Huseni
Shehlanoor Huseni
DPDiego Preciado
Diego Preciado
RFRobert J. Freishtat
Robert J. Freishtat
GNGustavo Nino
Gustavo Nino

29 December 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
GNGustavo Nino
Gustavo Nino
SHShehlanoor Huseni
Shehlanoor Huseni
GPGeovanny Perez
Geovanny Perez
KPKrishna Pancham
Krishna Pancham
HMHumaira Mubeen
Humaira Mubeen
MRMary C. Rose
Mary C. Rose
Thymic stromal lymphoproetin (TSLP) is a cytokine secreted by the airway epithelium in response to respiratory viruses and it is known to promote allergic Th2 responses in asthma. This study investigated whether virally-induced secretion of TSLP is directional in nature (apical vs. basolateral) and/or if there are TSLP-mediated effects occurring at both sides of the bronchial epithelial barrier in the asthmatic state. Primary human bronchial epithelial cells (HBEC) from control (n = 3) and asthmatic (n = 3) donors were differentiated into polarized respiratory tract epithelium under air-liquid interface (ALI) conditions and treated apically with dsRNA (viral surrogate) or TSLP. Sub-epithelial effects of TSLP were examined in human airway smooth muscle cells (HASMC) from normal (n = 3) and asthmatic (n = 3) donors. Clinical experiments examined nasal airway secretions obtained from asthmatic children during naturally occurring rhinovirus-induced exacerbations (n = 20) vs. non-asthmatic uninfected controls (n = 20). Protein levels of TSLP, CCL11/eotaxin-1, CCL17/TARC, CCL22/MDC, TNF-α and CXCL8 were determined with a multiplex magnetic bead assay. Our data demonstrate that: 1) Asthmatic HBEC exhibit an exaggerated apical, but not basal, secretion of TSLP after dsRNA exposure; 2) TSLP exposure induces unidirectional (apical) secretion of CCL11/eotaxin-1 in asthmatic HBEC and enhanced CCL11/eotaxin-1 secretion in asthmatic HASMC; 3) Rhinovirus-induced asthma exacerbations in children are associated with in vivo airway secretion of TSLP and CCL11/eotaxin-1. There are virally-induced TSLP-driven secretory immune responses at both sides of the bronchial epithelial barrier characterized by enhanced CCL11/eotaxin-1 secretion in asthmatic airways. These results suggest a new model of TSLP-mediated eosinophilic responses in the asthmatic airway during viral-induced exacerbations.